Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 478-5685

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

20.02.2019 - 21.02.2019

RNA Therapeutics 2019

Location
Copthorne Tara Hotel London Kensington, Scarsdale Place, Greater London, W8 5SY
Contact

Pav Solanki

psolanki@smi-online.co.uk

2078276048

Country
United Kingdom
Subject area(s)
Shortinfo

Fulfilling the potential of genetic discoveries requires the development of therapeutics that can specifically modulate the expression of disease-relevant genes. RNA-based drugs and antisense nucleotides, are promising examples of a newer class of biologics. Researchers have tried to overcome the major challenges for utilising RNAs in a therapeutic context, including: intracellular delivery, stability and immunogenicity.


Bringing together industry experts, to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression and genome editing


KEYNOTE SPEAKERS

• Ekkehard Leberer, Senior Director, Alliance Management, Sanofi

• Shalini Andersson, Senior Director and Head of New Modalities, AstraZeneca

• Carsten Rudolf, Chief Executive Officer, Ethris Gmbh

• Paul Agris, Founder and Director, The RNA Institute

• Marian Gindy, Executive Director, Pharmaceutical Sciences, Merck Research Labs, Merck and Co

• David Giljohan, CEO, Exicure

• Ingmar Hoerr, Founder and CEO, CureVac AG

• David Blakey, Chief Scientific Officer, MiNA Therapeutics

• André Gerber, Professor of RNA Biology, University of Surrey

• Heinrich Haas, Vice President Drug Delivery, BioNTech RNA Pharmaceuticals

• Markus Mandler, Chief Scientific Officer, Accanis Biotech

• Troels Koch, Vice President and Head of Research, RNA Therapeutics, Roche

• Hans Kistemaker, Associate Director, ProQR


HIGHLIGHTS

- Discover the clinical progress of Spherical Nucleic Acids

- Understand Sanofi’s strategies to deliver therapeutic oligonucleotides across biobarriers

- Learn from ProQR how to plan for oligonucleotide supply from personalized medicine to large scale markets

- Explore the development of small activating RNA – from bench to bedside with MiNA Therapeutics

- Gain insight into the discovery and development of self-amplifying mRNA vaccines at GSK